Opinion: How to ensure regulations don’t stymie much-needed COVID-19 point-of-care testing

摘要

The coronavirus disease 2019 (COVID-19) pandemic has raged for more than a year in the United States, upending life as we knew it. Nevertheless, we have seen incredibly rapid advances in vaccines, therapeutics, and diagnostic testing technology. There is tremendous need and economic interest in reopening our businesses and schools and in resuming gatherings for entertainment and sporting events. To accomplish this, we need a strong multifaceted strategy. Already, widespread vaccination is well underway. But those efforts must be coupled with aggressive community-based COVID point-of-care testing so that any case of asymptomatic infection, especially in the most transmissible phase, is rapidly identified (1).